Evaluation of Insuman Implantable 400 IU/ml in Patients With Type 1 Diabetes Treated With the Medtronic MiniMed Implantable Pump System Using Insuplant 400IU/ml
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi
- 14 Feb 2018 Status changed from active, no longer recruiting to completed.
- 10 Jan 2018 Planned End Date changed from 1 Sep 2017 to 31 Jan 2018.
- 10 Jan 2018 Planned primary completion date changed from 1 Sep 2017 to 31 Jan 2018.